Assessment of Predictors of Left Atrial Volume Response to a Transcatheter InterAtrial Shunt Device (from the REDUCE LAP-HF Trial)
Year: 2019
Type: article
Institutions: Hospital of the University of Pennsylvania, Baker Heart and Diabetes Institute, The Alfred Hospital, St Vincent's Hospital Sydney, St. Antonius Ziekenhuis, Na Homolce Hospital, University of Göttingen, Rigshospitalet, Cardiovascular Research Foundation, Northwestern University, Medical University of South Carolina, The Ohio State University Wexner Medical Center, University of Michigan, VA Ann Arbor Healthcare System, Michigan Medicine, Mayo Clinic, Brigham and Women's Hospital, National University of Singapore, Duke-NUS Medical School, Corvia Medical (United States)
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Awards: Transition from Risk Factors to Early HF: Prevalence, Pathogenesis, and Phenomics, Machine learning for the automated identification and tracking of rare myocardial diseases, Molecular Determinants of Hypertensive HFpEF: Genomics, Transcriptomics, and Proteomics, Determinants, Trajectories, and Consequences of Abnormal Cardiac Mechanics, Role of Female Sex and Hormone Status on HFpEF Pathophysiology and Therapy
OpenAlex ID: W2976818743